Vitamin C buyers certified to bring class action suit against Chinese pharma companies
U.S. District Judge Brian M. Cogan certified a class of Vitamin C buyers to bring a price-fixing suit against Chinese pharmaceutical companies. The defendants North China Pharmaceutical Co., Aland (Jiangsu) Nutraceutical Co., Northeast Pharmaceutical Co. and Weisheng Pharmaceutical Co. were found to have more than 60 percent world market share for Vitamin C.
Featured News
Butterball Moves to End Turkey Antitrust Litigation With $34M Pact
Aug 23, 2026 by
CPI
Uber’s California Racketeering Case Against Lawyers, Doctors Moves Forward
Aug 23, 2026 by
CPI
Epic Challenges Apple’s Compliance With Brazil App Store Antitrust Settlement
Aug 23, 2026 by
CPI
EU Ends Pratt & Whitney Canada Antitrust Probe After Contract Changes
Aug 23, 2026 by
CPI
Paramount, California to Meet Monday on Antitrust Settlement
Aug 23, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes